Unique ID issued by UMIN | UMIN000039045 |
---|---|
Receipt number | R000044524 |
Scientific Title | Phase 1 multi-center study of safety and feasibility of chemoradiotherapy using oxydol for cervical cancer |
Date of disclosure of the study information | 2020/01/06 |
Last modified on | 2020/01/03 00:32:52 |
Phase 1 multi-center study of safety and feasibility of chemoradiotherapy using oxydol for cervical cancer
Pilot study of chemoradiotherapy using oxydol for cervical cancer
Phase 1 multi-center study of safety and feasibility of chemoradiotherapy using oxydol for cervical cancer
Pilot study of chemoradiotherapy using oxydol for cervical cancer
Japan |
cervical cancer
Obstetrics and Gynecology |
Malignancy
NO
Analyze the feasibility and safety using hydrogen peroxide as a substitute of brachytherapy for cervical cancer
Safety,Efficacy
Exploratory
Phase I
1 month after treatment completion, 1 year, 2 years overall survival, disease-free survival and progression-free survival
Type, severity, and ratio of adverse events that occurred up to the date of follow-up observation
Interventional
Single arm
Non-randomized
Open -no one is blinded
Historical
NO
YES
Institution is considered as a block.
YES
Central registration
1
Treatment
Medicine |
Hydrogen peroxide was to be used twice a week (Monday and Thursday/Tuesday and Friday) in combination with CCRT. We inserted 3% hydrogen peroxide solution-soaked gauze into vagina firmly contact to the lesion immediately before RT and removed it right after RT.This procedure was done by the attending gynecologist.
20 | years-old | <= |
90 | years-old | >= |
Female
we recruited patients who have cervical caner needed radio-sensitization treatment because of unfeasibility to the standard therapy. Our selection criteria are as follow: cervical cancer patient; radical CCRT purpose; impossible or refusal of brachytherapy; 20 years or older ; without hematogenous metastasis ; having a ECOG Performance Status up to 2, and no pathological limitation, without prior treatment.
less than 20 years old
having distant metastasis
20
1st name | yuko |
Middle name | anne |
Last name | saito |
Juntendo University Urayasu Hospital
Department of Radiation Oncology
279-0021
2-1-1 Tomioka, Urayasu-shi, Chiba
047-353-3111
anyusaike@yahoo.co.jp
1st name | yuko |
Middle name | anne |
Last name | saito |
Juntendo University Urayasu Hospital
Department of Radiation Oncology
279-0021
2-1-1 Tomioka, Urayasu-shi, Chiba
047-353-3111
anyusaike@yahoo.co.jp
Juntendo University Urayasu Hospital
Juntendo University Urayasu Hospital
Self funding
Juntendo University Urayasu Hospital
2-1-1 Tomioka, Urayasu-shi, Chiba
047-353-3111
anyusaike@yahoo.co.jp
NO
2020 | Year | 01 | Month | 06 | Day |
Unpublished
20
Completed
2014 | Year | 01 | Month | 05 | Day |
2013 | Year | 08 | Month | 01 | Day |
2014 | Year | 02 | Month | 01 | Day |
2019 | Year | 08 | Month | 31 | Day |
2019 | Year | 08 | Month | 31 | Day |
2019 | Year | 08 | Month | 31 | Day |
2020 | Year | 12 | Month | 31 | Day |
2020 | Year | 01 | Month | 03 | Day |
2020 | Year | 01 | Month | 03 | Day |
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000044524
Research Plan | |
---|---|
Registered date | File name |
Research case data specifications | |
---|---|
Registered date | File name |
Research case data | |
---|---|
Registered date | File name |